High-grade brain tumors overexpress EMMPRIN and EMMPRIN expression positively correlates with WHO grades in human astrocytomas and meningiomas, suggesting that EMMPRIN may be a therapeutic target of brain tumor. This evidence concerns the gene BSG and meningioma.